X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, announces that...
cell therapy
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the...
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy...
Synthego Bridges Critical Preclinical Gap to Accelerate CRISPR-based Cell and Gene Therapies
2 min read
Synthego, a leading provider of genome engineering solutions, today announced the launch of its IND-enabling (INDe) gRNAs,...